Actively Recruiting

Age: 18Years +
All Genders
NCT06711159

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

Led by Zealand University Hospital · Updated on 2024-12-02

15

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

Sponsors

Z

Zealand University Hospital

Lead Sponsor

U

UNEEG Medical A/S

Collaborating Sponsor

AI-Summary

What this Trial Is About

Study aim: This study aims to use a new brainwave monitoring device that meassure brainwaves 24 hours a day to create better understanding of sleep-wake interplay as a biomarker for excessive daytime sleepiness because of obstructive sleep apnea. Study Method, Design, and Procedures Patients with sleep apnea referred to the Sleep Clinic at the Department of Ear, Nose, Throat, and Jaw Surgery in Køge for CPAP treatment, who also experience severe daytime sleepiness, will be offered participation in this study. The goal is for 15 participants to complete the entire protocol. Procedure Overview Initial Sleep Assessment: The study begins with an in-depth sleep assessment through polysomnography (PSG) followed by a Multiple Sleep Latency Test (MSLT). PSG: This sleep study evaluates sleep structure, confirms sleep apnea, and rules out other sleep disorders. MSLT: This test measures the brain's tendency to fall asleep during the day. Additional Home-Based Sleep Studies: Participants will undergo two more PSG studies in their homes. EEG Monitoring: After the initial assessments, participants will have a small EEG electrode implanted to monitor brain activity. The implant, a CE-certified device called 24/7 EEG™ SubQ, will be inserted under local anesthesia by an experienced surgeon. Once post-surgery swelling subsides (after about 7-10 days), continuous EEG monitoring will begin, where participants connect an external data storage device during the day. The device records for 12 weeks, and CPAP treatment begins around the 6-week mark. After 12 weeks, the EEG device is removed, and the study ends. Aditional Data Collection (Optional) During the 12 weeks of EEG recording, participants are asked to report: Sleep Diary: Log daytime sleep episodes, including planned naps and unintended naps. Questionnaires and Tests: Complete daily questionnaires about fatigue symptoms and perform a brief attention and reaction test. These tasks take 3-10 minutes each day and are accessible via smartphone or tablet. Interviews and Movement Tracking: Participants may also be invited to interviews on how sleepiness affects their daily life and asked to wear a motion-tracking watch to monitor activity.

CONDITIONS

Official Title

SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with severe obstructive sleep apnea (AHI > 30) and not started any PAP treatment
  • Epworth Sleepiness Scale (ESS) score above 10 at time of inclusion
Not Eligible

You will not qualify if you...

  • Known severe neurological or psychiatric diseases
  • Known congestive heart failure, chronic renal failure, liver failure, malignancy, severe pulmonary disease
  • Considerable use of alcohol
  • Medication that influences sleep/wake regulation affecting data quality
  • Presence of cochlear implants
  • Undergoing therapies with medical devices delivering electrical energy near the implant
  • High risk of surgical complications such as active infection or bleeding disorders
  • Unable or lacking assistance to properly operate the device system
  • Infection at the device implantation site
  • Operating MRI scanners
  • Profession or hobby with extreme pressure variations (e.g., diving or parachute jumping) except diving/snorkeling up to 5 meters
  • Profession or hobby with risk of trauma to device or implant site (e.g., martial arts, boxing)
  • Other diseases or conditions affecting sleep compromising data quality
  • Incapable of understanding or completing study requirements
  • Pregnant or intending pregnancy within 12 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zealand University Hospital

Koege, Regional Zealand, Denmark, 4600

Actively Recruiting

Loading map...

Research Team

M

Mathias Sarkez-Knudsen, MD

CONTACT

P

Preben Homøe, Professor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here